Other Species / Isoforms
  HP1 alpha (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T8-p
MGKKTKRtADssssE
0 8
HP1 alpha (human) MGKKTKRtADssssE T8-p
HP1 alpha (mouse) MGKKTKRtADssssE T8-p
HP1 alpha (rat) MGKKTKRTADSSSsE T8
S11-p
KTKRtADssssEDEE
1 27
HP1 alpha (human) KTKRtADssssEDEE S11-p
HP1 alpha (mouse) KTKRtADssssEDEE S11-p
HP1 alpha (rat) KTKRTADSSSsEDEE S11
S12-p
TKRtADssssEDEEE
1 29
HP1 alpha (human) TKRtADssssEDEEE S12-p
HP1 alpha (mouse) TKRtADssssEDEEE S12-p
HP1 alpha (rat) TKRTADSSSsEDEEE S12
S13-p
KRtADssssEDEEEy
1 35
HP1 alpha (human) KRtADssssEDEEEy S13-p
HP1 alpha (mouse) KRtADssssEDEEEy S13-p
HP1 alpha (rat) KRTADSSSsEDEEEY S13
S14-p
RtADssssEDEEEyV
Upstream
1 44
Treatment
  • MLN8054
HP1 alpha (human) RtADssssEDEEEyV S14-p
HP1 alpha (mouse) RtADssssEDEEEyV S14-p
HP1 alpha (rat) RTADSSSsEDEEEYV S14-p
Y20-p
ssEDEEEyVVEKVLD
0 3
HP1 alpha (human) ssEDEEEyVVEKVLD Y20-p
HP1 alpha (mouse) ssEDEEEyVVEKVLD Y20-p
HP1 alpha (rat) SsEDEEEYVVEKVLD Y20
K32-ub
VLDRRVVkGQVEyLL
0 7
HP1 alpha (human) VLDRRVVkGQVEyLL K32-ub
HP1 alpha (mouse) VLDRRMVkGQVEYLL K32-ub
HP1 alpha (rat) VLDRRMVKGQVEYLL K32
K32-sm
VLDRRVVkGQVEyLL
0 1
HP1 alpha (human) VLDRRVVkGQVEyLL K32-sm
HP1 alpha (mouse) VLDRRMVKGQVEYLL K32
HP1 alpha (rat) VLDRRMVKGQVEYLL K32
K32-m1
VLDRRVVkGQVEyLL
0 1
HP1 alpha (human) VLDRRVVkGQVEyLL K32-m1
HP1 alpha (mouse) VLDRRMVKGQVEYLL K32
HP1 alpha (rat) VLDRRMVKGQVEYLL K32
Y37-p
VVkGQVEyLLkWkGF
0 1
HP1 alpha (human) VVkGQVEyLLkWkGF Y37-p
HP1 alpha (mouse) MVkGQVEYLLKWKGF Y37
HP1 alpha (rat) MVKGQVEYLLKWKGF Y37
K40-ac
GQVEyLLkWkGFsEE
0 1
HP1 alpha (human) GQVEyLLkWkGFsEE K40-ac
HP1 alpha (mouse) GQVEYLLKWKGFSEE K40
HP1 alpha (rat) GQVEYLLKWKGFSEE K40
K40-ub
GQVEyLLkWkGFsEE
0 3
HP1 alpha (human) GQVEyLLkWkGFsEE K40-ub
HP1 alpha (mouse) GQVEYLLKWKGFSEE K40
HP1 alpha (rat) GQVEYLLKWKGFSEE K40
K40-m1
GQVEyLLkWkGFsEE
0 1
HP1 alpha (human) GQVEyLLkWkGFsEE K40-m1
HP1 alpha (mouse) GQVEYLLKWKGFSEE K40
HP1 alpha (rat) GQVEYLLKWKGFSEE K40
K42-ub
VEyLLkWkGFsEEHN
0 2
HP1 alpha (human) VEyLLkWkGFsEEHN K42-ub
HP1 alpha (mouse) VEYLLKWKGFSEEHN K42
HP1 alpha (rat) VEYLLKWKGFSEEHN K42
S45-p
LLkWkGFsEEHNTWE
0 2
HP1 alpha (human) LLkWkGFsEEHNTWE S45-p
HP1 alpha (mouse) LLKWKGFSEEHNTWE S45
HP1 alpha (rat) LLKWKGFSEEHNTWE S45
K55-ac
HNTWEPEkNLDCPEL
0 1
HP1 alpha (human) HNTWEPEkNLDCPEL K55-ac
HP1 alpha (mouse) HNTWEPEKNLDCPEL K55
HP1 alpha (rat) HNTWEPEKNLDCPEL K55
K55-ub
HNTWEPEkNLDCPEL
0 3
HP1 alpha (human) HNTWEPEkNLDCPEL K55-ub
HP1 alpha (mouse) HNTWEPEKNLDCPEL K55
HP1 alpha (rat) HNTWEPEKNLDCPEL K55
K68-ub
ELISEFMkKYKKMKE
0 2
HP1 alpha (human) ELISEFMkKYKKMKE K68-ub
HP1 alpha (mouse) ELISEFMkKYKKMKE K68-ub
HP1 alpha (rat) ELISEFMKKYKKMKE K68
K80-ub
MKEGENNkPREKSES
0 1
HP1 alpha (human) MKEGENNkPREKSES K80-ub
HP1 alpha (mouse) MKEGENNKPREKSEG K80
HP1 alpha (rat) MKEGENNKPREKSEG K80
K91-ac
KSESNKRksNFsNsA
0 1
HP1 alpha (human) KSESNKRksNFsNsA K91-ac
HP1 alpha (mouse) KSEGNKRKssFsNsA K91
HP1 alpha (rat) KSEGNKRKssFSNsA K91
K91-ub
KSESNKRksNFsNsA
0 12
HP1 alpha (human) KSESNKRksNFsNsA K91-ub
HP1 alpha (mouse) KSEGNKRkssFsNsA K91-ub
HP1 alpha (rat) KSEGNKRKssFSNsA K91
K91-m1
KSESNKRksNFsNsA
0 1
HP1 alpha (human) KSESNKRksNFsNsA K91-m1
HP1 alpha (mouse) KSEGNKRKssFsNsA K91
HP1 alpha (rat) KSEGNKRKssFSNsA K91
S92-p
SESNKRksNFsNsAD
Upstream
Downstream
3 57
Effects on Biological Processes:
  • cell cycle regulation
  • chromatin organization, altered
Kinase, in vitro:
  • AurB (human)
Putative in vivo kinases:
  • AurB (human)
Treatment
  • anti-CD3
  • BI_4834
  • hesperadin
  • MG132
  • MG132_withdrawal
  • MLN8054
  • nocodazole
  • siRNA
  • ZK-Thiazolidinone
HP1 alpha (human) SESNKRksNFsNsAD S92-p
HP1 alpha (mouse) SEGNKRkssFsNsAD S92-p
HP1 alpha (rat) SEGNKRKssFSNsAD S92-p
N93
ESNKRksNFsNsADD
1 66
HP1 alpha (human) ESNKRksNFsNsADD N93
HP1 alpha (mouse) EGNKRkssFsNsADD S93-p
HP1 alpha (rat) EGNKRKssFSNsADD S93-p
S95-p
NKRksNFsNsADDIk
1 16
HP1 alpha (human) NKRksNFsNsADDIk S95-p
HP1 alpha (mouse) NKRkssFsNsADDIk S95-p
HP1 alpha (rat) NKRKssFSNsADDIK S95
S97-p
RksNFsNsADDIkSk
Upstream
1 24
Treatment
  • nocodazole
  • ZK-Thiazolidinone
HP1 alpha (human) RksNFsNsADDIkSk S97-p
HP1 alpha (mouse) RkssFsNsADDIkSK S97-p
HP1 alpha (rat) RKssFSNsADDIKSK S97-p
K102-ub
sNsADDIkSkKkREQ
0 14
HP1 alpha (human) sNsADDIkSkKkREQ K102-ub
HP1 alpha (mouse) sNsADDIkSKKKREQ K102-ub
HP1 alpha (rat) SNsADDIKSKKKREQ K102
K102-sm
sNsADDIkSkKkREQ
0 2
HP1 alpha (human) sNsADDIkSkKkREQ K102-sm
HP1 alpha (mouse) sNsADDIKSKKKREQ K102
HP1 alpha (rat) SNsADDIKSKKKREQ K102
K104-ub
sADDIkSkKkREQsN
0 2
HP1 alpha (human) sADDIkSkKkREQsN K104-ub
HP1 alpha (mouse) sADDIkSKKKREQsN K104
HP1 alpha (rat) sADDIKSKKKREQSN K104
K106-ac
DDIkSkKkREQsNDI
0 1
HP1 alpha (human) DDIkSkKkREQsNDI K106-ac
HP1 alpha (mouse) DDIkSKKKREQsNDI K106
HP1 alpha (rat) DDIKSKKKREQSNDI K106
K106-ub
DDIkSkKkREQsNDI
0 1
HP1 alpha (human) DDIkSkKkREQsNDI K106-ub
HP1 alpha (mouse) DDIkSKKKREQsNDI K106
HP1 alpha (rat) DDIKSKKKREQSNDI K106
S110-p
SkKkREQsNDIArGF
Upstream
0 8
Treatment
  • MG132_withdrawal
HP1 alpha (human) SkKkREQsNDIArGF S110-p
HP1 alpha (mouse) SKKKREQsNDIARGF S110-p
HP1 alpha (rat) SKKKREQSNDIARGF S110
R115-m1
EQsNDIArGFErGLE
0 1
HP1 alpha (human) EQsNDIArGFErGLE R115-m1
HP1 alpha (mouse) EQsNDIARGFERGLE R115
HP1 alpha (rat) EQSNDIARGFERGLE R115
R119-m1
DIArGFErGLEPEkI
0 1
HP1 alpha (human) DIArGFErGLEPEkI R119-m1
HP1 alpha (mouse) DIARGFERGLEPEkI R119
HP1 alpha (rat) DIARGFERGLEPEKI R119
K125-ub
ErGLEPEkIIGAtDs
0 26
HP1 alpha (human) ErGLEPEkIIGAtDs K125-ub
HP1 alpha (mouse) ERGLEPEkIIGATDs K125-ub
HP1 alpha (rat) ERGLEPEKIIGATDS K125
T130-p
PEkIIGAtDsCGDLM
0 1
HP1 alpha (human) PEkIIGAtDsCGDLM T130-p
HP1 alpha (mouse) PEkIIGATDsCGDLM T130
HP1 alpha (rat) PEKIIGATDSCGDLM T130
S132-p
kIIGAtDsCGDLMFL
0 6
HP1 alpha (human) kIIGAtDsCGDLMFL S132-p
HP1 alpha (mouse) kIIGATDsCGDLMFL S132-p
HP1 alpha (rat) KIIGATDSCGDLMFL S132
K143-ac
LMFLMKWkDTDEADL
0 1
HP1 alpha (human) LMFLMKWkDTDEADL K143-ac
HP1 alpha (mouse) LMFLMKWKDTDEADL K143
HP1 alpha (rat) LMFLMKWKDTDEADL K143
K143-ub
LMFLMKWkDTDEADL
0 4
HP1 alpha (human) LMFLMKWkDTDEADL K143-ub
HP1 alpha (mouse) LMFLMKWkDTDEADL K143-ub
HP1 alpha (rat) LMFLMKWKDTDEADL K143
K143-m1
LMFLMKWkDTDEADL
0 1
HP1 alpha (human) LMFLMKWkDTDEADL K143-m1
HP1 alpha (mouse) LMFLMKWKDTDEADL K143
HP1 alpha (rat) LMFLMKWKDTDEADL K143
K154-ub
EADLVLAkEANVkCP
Upstream
0 46
Treatment
  • vorinostat
HP1 alpha (human) EADLVLAkEANVkCP K154-ub
HP1 alpha (mouse) EADLVLAkEANVkCP K154-ub
HP1 alpha (rat) EADLVLAKEANVKCP K154
K154-sm
EADLVLAkEANVkCP
0 1
HP1 alpha (human) EADLVLAkEANVkCP K154-sm
HP1 alpha (mouse) EADLVLAKEANVkCP K154
HP1 alpha (rat) EADLVLAKEANVKCP K154
K154-m2
EADLVLAkEANVkCP
0 1
HP1 alpha (human) EADLVLAkEANVkCP K154-m2
HP1 alpha (mouse) EADLVLAKEANVkCP K154
HP1 alpha (rat) EADLVLAKEANVKCP K154
K159-ub
LAkEANVkCPQIVIA
0 8
HP1 alpha (human) LAkEANVkCPQIVIA K159-ub
HP1 alpha (mouse) LAkEANVkCPQIVIA K159-ub
HP1 alpha (rat) LAKEANVKCPQIVIA K159
Y177-p
ERLTWHAyPEDAENk
0 3
HP1 alpha (human) ERLTWHAyPEDAENk Y177-p
HP1 alpha (mouse) ERLTWHAYPEDAENk Y177
HP1 alpha (rat) ERLTWHAYPEDAENK Y177
K184-ub
yPEDAENkEKEtAKs
0 12
HP1 alpha (human) yPEDAENkEKEtAKs K184-ub
HP1 alpha (mouse) YPEDAENkEKESAKS K184-ub
HP1 alpha (rat) YPEDAENKEKESAKS K184
T188-p
AENkEKEtAKs____
0 2
HP1 alpha (human) AENkEKEtAKs____ T188-p
HP1 alpha (mouse) AENkEKESAKS____ S188
HP1 alpha (rat) AENKEKESAKS____ S188
S191-p
kEKEtAKs_______
0 2
HP1 alpha (human) kEKEtAKs_______ S191-p
HP1 alpha (mouse) kEKESAKS_______ S191
HP1 alpha (rat) KEKESAKS_______ S191